Want to see OSCR full AI Analyst Report?
OSCR Stock Chart & Stats
$28.19
$0.77(2.73%)
At close: 4:00 PM EDT
$28.19
$0.77(2.73%)
Day’s Range― - ―
52-Week Range$10.69 - $33.10
Previous CloseN/A
Volume8.39K
Average Volume (3M)5.26M
Market Cap
$9.41B
Enterprise Value$9.94K
Total Cash (Recent Filing)$8.56B
Total Debt (Recent Filing)$431.63M
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Nov 10, 2026EPS Estimate
-0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.71
Shares Outstanding265,902,000
10 Day Avg. Volume3,962,270
30 Day Avg. Volume5,255,678
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.86
Price to Sales (P/S)0.32
P/FCF Ratio3.56
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$28.63Price Target Upside1.54% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.1
Revenue Forecast (FY)$18.55B
Bulls Say, Bears Say
Bulls Say
Cash GenerationSustained operating cash flow (~$4.42B TTM) and free cash flow (~$4.38B) provide durable internal funding for claims volatility, working capital and growth investments. Strong FCF reduces reliance on external financing and supports insurance subsidiary capital and reserve flexibility over months.
Membership & Revenue ScaleRapid scaling—membership nearly 3.0M (+46% YoY) and materially higher revenue—improves risk pooling and spreads fixed tech and SG&A across more lives. A larger premium base supports underwriting leverage and gives management room to refine pricing and network contracts over multi-month horizons.
Technology / AI-driven EfficiencyHigh first-pass claims accuracy and AI-driven pharmacy/medical-economics savings create a durable cost and service advantage. Tech lowers marginal processing costs, supports lower SG&A ratios, speeds member experience, and scales as membership grows, reinforcing long-term operating leverage.
Bears Say
Profitability VolatilityEarnings have swung between losses and profits across recent years and margins remain thin, which undermines predictability of returns. This volatility means underwriting or utilization shocks can quickly reverse recent gains and complicate multi-month forecasting of durable profitability.
CMS Eligibility / Program-integrity RiskRegulatory-driven removals and eligibility reviews are structural risks for ACA insurers. Elevated churn from CMS actions can shrink the premium base, alter morbidity mix, and force conservative reserving, reducing revenue visibility and pressuring margins over the coming months.
Risk-adjustment / Prior-period Development RelianceMaterial reliance on risk-adjustment transfers and prior-period development introduces earnings and reserve volatility. RA swings, audits or formula changes can materially affect reported earnings and capital, complicating durable forecasting of underwriting results and capital needs.
Oscar Health News
OSCR FAQ
What was Oscar Health, Inc.’s price range in the past 12 months?
Oscar Health, Inc. lowest stock price was $10.69 and its highest was $33.10 in the past 12 months.
What is Oscar Health, Inc.’s market cap?
Oscar Health, Inc.’s market cap is $9.41B.
When is Oscar Health, Inc.’s upcoming earnings report date?
Oscar Health, Inc.’s upcoming earnings report date is Nov 10, 2026 which is in 93 days.
How were Oscar Health, Inc.’s earnings last quarter?
Oscar Health, Inc. released its earnings results on Aug 06, 2026. The company reported $1.1 earnings per share for the quarter, beating the consensus estimate of $0.403 by $0.697.
Is Oscar Health, Inc. overvalued?
According to Wall Street analysts Oscar Health, Inc.’s price is currently Undervalued.
Does Oscar Health, Inc. pay dividends?
Oscar Health, Inc. does not currently pay dividends.
What is Oscar Health, Inc.’s EPS estimate?
Oscar Health, Inc.’s EPS estimate is -0.21.
How many shares outstanding does Oscar Health, Inc. have?
Oscar Health, Inc. has 265,902,000 shares outstanding.
What happened to Oscar Health, Inc.’s price movement after its last earnings report?
Oscar Health, Inc. reported an EPS of $1.1 in its last earnings report, beating expectations of $0.403. Following the earnings report the stock price went down -11.857%.
Which hedge fund is a major shareholder of Oscar Health, Inc.?
Currently, no hedge funds are holding shares in OSCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oscar Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$28.63 (1.54% Upside)
$28.63 (1.54% Upside)
Blogger Sentiment
Bullish
OSCR Sentiment 90%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 676.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
98.52%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
78.15%
Trailing 12-Months
Company Description
Oscar Health, Inc.
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
OSCR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys materially positive operating momentum: very strong revenue growth, sizeable membership expansion, record-low SG&A, marked improvement in profitability metrics and a raised earnings outlook. Management also emphasized technology and AI-driven efficiency gains and favorable risk‑adjustment developments that underpin the improved guidance. Offsetting items include an ongoing industry-wide ACA market contraction, elevated outpatient utilization and medical PMPM seasonality, and near-term uncertainty from CMS eligibility/program-integrity actions and limited early-year morbidity data. On balance, the positive operational and financial drivers substantially outweigh the risks flagged for the back half of the year.View all OSCR earnings summariesOSCR Stock 12 Month Forecast
Average Price Target
$28.63
▲(1.54% Upside)
Technical Analysis
Centene
―
Humana
―
Molina Healthcare
―
Clover Health Investments
―
Alignment Healthcare
―
Ownership Overview
4.53% Insiders
16.63% Mutual Funds
4.29% Other Institutional Investors
55.56% Public Companies and Individual Investors